BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33685727)

  • 1. Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study.
    Corso G; Magnoni F; Montagna G; Maisonneuve P; Polizzi A; Massari G; Invento A; Girardi A; De Scalzi AM; Veronesi P
    Eur J Surg Oncol; 2021 Jul; 47(7):1593-1600. PubMed ID: 33685727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
    Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
    Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer.
    Poodt IGM; Schipper RJ; Vugts G; Woensdregt K; van der Sangen M; Voogd AC; Nieuwenhuijzen GAP
    Eur J Surg Oncol; 2018 Nov; 44(11):1714-1719. PubMed ID: 30082177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.
    Matsen C; Villegas K; Eaton A; Stempel M; Manning A; Cody HS; Morrow M; Heerdt A
    Ann Surg Oncol; 2016 Aug; 23(8):2456-61. PubMed ID: 26957506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.
    Pernas S; Gil M; Benítez A; Bajen MT; Climent F; Pla MJ; Benito E; Guma A; Gutierrez C; Pisa A; Urruticoechea A; Pérez J; Gil Gil M
    Ann Surg Oncol; 2010 Mar; 17(3):772-7. PubMed ID: 20183912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.
    Biglia N; Bounous VE; Gallo M; Fuso L; Sgro LG; Maggiorotto F; Ponzone R
    Breast; 2018 Oct; 41():8-13. PubMed ID: 29933180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.
    Tokmak H; Kaban K; Muslumanoglu M; Demirel M; Aktan S
    World J Surg Oncol; 2014 Jul; 12():205. PubMed ID: 25016393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer.
    Andersson Y; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Bergkvist L; Frisell J; ;
    Br J Surg; 2012 Feb; 99(2):226-31. PubMed ID: 22180063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
    Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
    Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgery.
    Matsumoto A; Jinno H; Nakamura T; Saito J; Takahashi M; Hayashida T; Kameyama K; Kitagawa Y
    Int J Surg; 2015 Oct; 22():28-31. PubMed ID: 26278666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer.
    Gauthier T; Mollard J; Fermeaux V; Kapella M; Aubard Y
    Eur J Surg Oncol; 2009 May; 35(5):464-8. PubMed ID: 18977110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and recurrence with or without axillary dissection in patients with invasive breast cancer and sentinel node metastasis.
    Sanvido VM; Elias S; Facina G; Bromberg SE; Nazário ACP
    Sci Rep; 2021 Oct; 11(1):19893. PubMed ID: 34615952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.